Safety of anti‐tumour necrosis factor‐α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of …

C Fotiadou, E Lazaridou… - Journal of the European …, 2011 - Wiley Online Library
Background Issues concerning the potential risks of reactivating chronic hepatitis B virus
arise when the use of anti‐Tumour Necrosis Factor‐α (TNFα) agents is imperative in patients …
被引用次数：45 相关文章

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the …

C Fotiadou, E Lazaridou… - Journal of the …, 2011 - pubmed.ncbi.nlm.nih.gov
Background Issues concerning the potential risks of reactivating chronic hepatitis B virus
arise when the use of anti-Tumour Necrosis Factor-α (TNFα) agents is imperative in patients …

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the …

C Fotiadou, E Lazaridou… - Journal of the European …, 2011 - search.ebscohost.com
Issues concerning the potential risks of reactivating chronic hepatitis B virus arise when the
use of anti-Tumour Necrosis Factor-α (TNFα) agents is imperative in patients with concurrent …

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the …

C Fotiadou, E Lazaridou, D Ioannides - 2011 - cabidigitallibrary.org
Background: Issues concerning the potential risks of reactivating chronic hepatitis B virus
arise when the use of anti-Tumour Necrosis Factor-α (TNFα) agents is imperative in patients …

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the …

C Fotiadou, E Lazaridou, D Ioannides - Journal of the European …, 2011 - europepmc.org
Background Issues concerning the potential risks of reactivating chronic hepatitis B virus
arise when the use of anti-Tumour Necrosis Factor-α (TNFα) agents is imperative in patients …
[PDF] academia.edu

[PDF][PDF] Safety of anti-tumour necrosis factor-a agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review …

C Fotiadou, E Lazaridou, D Ioannides - academia.edu
Background Issues concerning the potential risks of reactivating chronic hepatitis B virus
arise when the use of anti-Tumour Necrosis Factor-o (TNFo) agents is imperative in patients …

Safety of anti‐tumour necrosis factor‐α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of …

C Fotiadou, E Lazaridou, D Ioannides - Journal of the European Academy …, 2011 - infona.pl
Background Issues concerning the potential risks of reactivating chronic hepatitis B virus
arise when the use of anti‐Tumour Necrosis Factor‐α (TNFα) agents is imperative in patients …

[引用][C] Safety of anti-tumor necrosis factor-alpha agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief …

C FOTIADOU - J Eur Acad Dermatol Venereol, 2011 - cir.nii.ac.jp
Safety of anti-tumor necrosis factor-alpha agents in psoriasis patients who were chronic
hepatitis B carriers : a retrospective report of seven patients and brief review of the literature …